Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan T Lei

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|March 26, 2021
Proteogenomics drives therapeutic hypothesis generation for precision oncologyJonathan T Lei, Bing Zhang
Journal of Leukocyte Biology|May 31, 2008
Separate endocytic pathways regulate IL-5 receptor internalization and signalingJonathan T Lei, Margarita Martinez-Moczygemba
Molecular & Cellular Oncology|December 8, 2018
<i>ESR1</i> fusions drive endocrine therapy resistance and metastasis in breast cancerJonathan T Lei, Xuxu Gou, Matthew J Ellis
The Journal of Biological Chemistry|October 4, 2011
Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signalingJonathan T Lei, Tuhina Mazumdar, Margarita Martinez-Moczygemba
Journal of Leukocyte Biology|January 18, 2007
JAK kinases control IL-5 receptor ubiquitination, degradation, and internalizationMargarita Martinez-Moczygemba, David P Huston, Jonathan T Lei
Journal of Cancer Metastasis and Treatment|May 21, 2019
<i>ESR1</i> alterations and metastasis in estrogen receptor positive breast cancerJonathan T Lei, Xuxu Gou, Sinem Seker, et al.
Nature Cancer|December 11, 2024
Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomicsZhiao Shi, Jonathan T Lei, John M Elizarraras, et al.
Breast (Edinburgh, Scotland)|December 17, 2019
Endocrine therapy resistance: new insightsJonathan T Lei, Meenakshi Anurag, Svasti Haricharan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identificationXinpei Yi, Bo Wen, Shuyi Ji, et al.
Cell Systems|August 24, 2023
A proteogenomics data-driven knowledge base of human cancerYuxing Liao, Sara R Savage, Yongchao Dou, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|March 26, 2021
Proteogenomics drives therapeutic hypothesis generation for precision oncologyJonathan T Lei, Bing Zhang
Journal of Leukocyte Biology|May 31, 2008
Separate endocytic pathways regulate IL-5 receptor internalization and signalingJonathan T Lei, Margarita Martinez-Moczygemba
Molecular & Cellular Oncology|December 8, 2018
<i>ESR1</i> fusions drive endocrine therapy resistance and metastasis in breast cancerJonathan T Lei, Xuxu Gou, Matthew J Ellis
The Journal of Biological Chemistry|October 4, 2011
Three lysine residues in the common β chain of the interleukin-5 receptor are required for Janus kinase (JAK)-dependent receptor ubiquitination, endocytosis, and signalingJonathan T Lei, Tuhina Mazumdar, Margarita Martinez-Moczygemba
Journal of Leukocyte Biology|January 18, 2007
JAK kinases control IL-5 receptor ubiquitination, degradation, and internalizationMargarita Martinez-Moczygemba, David P Huston, Jonathan T Lei
Journal of Cancer Metastasis and Treatment|May 21, 2019
<i>ESR1</i> alterations and metastasis in estrogen receptor positive breast cancerJonathan T Lei, Xuxu Gou, Sinem Seker, et al.
Nature Cancer|December 11, 2024
Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomicsZhiao Shi, Jonathan T Lei, John M Elizarraras, et al.
Breast (Edinburgh, Scotland)|December 17, 2019
Endocrine therapy resistance: new insightsJonathan T Lei, Meenakshi Anurag, Svasti Haricharan, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Deep learning prediction boosts phosphoproteomics-based discoveries through improved phosphopeptide identificationXinpei Yi, Bo Wen, Shuyi Ji, et al.
Cell Systems|August 24, 2023
A proteogenomics data-driven knowledge base of human cancerYuxing Liao, Sara R Savage, Yongchao Dou, et al.
Pageof 5